Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

Neurobiological markers across joint profiles of subjective cognitive decline and objective cognitive function in older adults

AI Summary
  • Joint subjective-objective cognitive profiles reflect biologically meaningful heterogeneity linked to neurodegeneration and brain ageing.
  • Profiles differed on plasma NfL and brain-predicted age difference, indicating neurodegeneration and accelerated brain ageing associations.
  • Concordant lower functioning profile showed higher NfL and lower volumetric AD signature; p-tau217 and GFAP did not vary across profiles.
Summarise with AI (MRCPsych/FRANZCP)

Alzheimers Dement. 2026 Aug;22(8):e71743. doi: 10.1002/alz.71743.

ABSTRACT

INTRODUCTION: Subjective cognitive concerns frequently diverge from objective cognitive performance in cognitively unimpaired (CU) older adults, yet the neurobiological basis of this mismatch remains unclear.

METHODS: In 648 participants from the Investigating Gains in Neurocognition in an Intervention Trial of Exercise (IGNITE), we defined four profiles by integrating subjective and objective cognitive status. We examined associations with plasma neurofilament light chain (NfL), phosphorylated tau 217 (p-tau217), glial fibrillary acidic protein (GFAP), a magnetic resonance imaging-based volumetric Alzheimer’s disease (AD) signature reflecting atrophy, and brain-predicted age difference (brain-PAD).

RESULTS: Joint profiles were differentially associated with NfL (P = 0.0427) and brain-PAD (P = 0.0296). Follow-up contrasts further indicated higher NfL and lower volumetric AD signature in the concordant lower functioning profile, and higher brain-PAD in discordant profiles. p-tau217 and GFAP did not differ across profiles.

DISCUSSION: Joint subjective-objective cognitive profiles may capture biologically meaningful heterogeneity relevant to neurodegeneration and brain aging in older adults.

TRIAL REGISTRATION: ClinicalTrials.gov: NCT02875301.

PMID:42576170 | DOI:10.1002/alz.71743

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

My Revision List

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review
← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD